BioCryst Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- BioCryst Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- BCRX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000882796
Board of directors
-
Alan G. Levin · DirectorSince 2023
-
Amy E. McKee · DirectorSince 2023
-
George B. Abercrombie · DirectorSince 2023
-
Jon P. Stonehouse · Director · President & CEOSince 2023
-
Kenneth B. Lee Jr. · DirectorSince 2023
-
Machelle Sanders · DirectorSince 2023
-
Nancy J. Hutson · DirectorSince 2023
-
Robert Alexander Ingram · DirectorSince 2023
-
Steve Aselage · DirectorSince 2023
-
Steven K. Galson · DirectorSince 2023
-
Theresa Heggie · DirectorSince 2023
-
Vincent Milano · DirectorSince 2023
Chief executives
Jon P. Stonehouse
· President & CEO
Dates unknown
Board connections
2 of this board's directors also sit on 2 other boards.
- via Vincent Milano
- via Machelle Sanders
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 28, 2025 | Vincent Milano Director | Grant or award | +653 | $8.61 | $5,622 |
| Dec 20, 2024 | Jon P. Stonehouse Director, Officer (President & CEO) | Gift | −20,000 | — | — |
| Dec 20, 2024 | Jon P. Stonehouse Director, Officer (President & CEO) | Gift | +10,000 | — | — |
| Dec 20, 2024 | Jon P. Stonehouse Director, Officer (President & CEO) | Gift | +10,000 | — | — |
| Dec 19, 2024 | Gayer Charles K Officer (Chief Commercial Officer) | Grant or award | +125,950 | — | — |
| Dec 19, 2024 | Thackray Helen M. Officer (Chief R&D Officer) | Grant or award | +125,950 | — | — |
| Dec 19, 2024 | Doyle Anthony Officer (Chief Financial Officer) | Grant or award | +120,700 | — | — |
| Dec 19, 2024 | Barnes Alane P Officer (Chief Legal Officer) | Grant or award | +120,700 | — | — |
| Dec 19, 2024 | Jon P. Stonehouse Director, Officer (President & CEO) | Grant or award | +362,100 | — | — |
| Dec 19, 2024 | Gayer Charles K Officer (Chief Commercial Officer) | Shares withheld for tax | −2,461 | $7.39 | $18,187 |
| Dec 19, 2024 | Thackray Helen M. Officer (Chief R&D Officer) | Shares withheld for tax | −6,096 | $7.39 | $45,049 |
| Dec 19, 2024 | Doyle Anthony Officer (Chief Financial Officer) | Shares withheld for tax | −2,461 | $7.39 | $18,187 |
| Dec 19, 2024 | Barnes Alane P Officer (Chief Legal Officer) | Shares withheld for tax | −2,461 | $7.39 | $18,187 |
| Dec 19, 2024 | Jon P. Stonehouse Director, Officer (President & CEO) | Shares withheld for tax | −14,010 | $7.39 | $103,534 |
| Dec 14, 2024 | Gayer Charles K Officer (Chief Commercial Officer) | Shares withheld for tax | −8,251 | $7.53 | $62,130 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.